It's a medical device that is already being put to good use, with the Shoreline team having already implanted the device in a ...

Despite advances in the treatment of myocardial infarction (MI), the incidence of cardiogenic shock has remained at 7% to 10% during the last 25 years. Hospital mortality was about 90% in the ...

Explore the latest innovations in cardiogenic shock treatment, including advances in mechanical circulatory support devices, ...

The following is a summary of “Corticosteroids in Cardiogenic Shock: A Retrospective Analysis of the Medical Information Mart ...

Windtree Therapeutics (WINT) announced that an istaroxime presentation featuring the positive Phase 2b SEISMiC study was given on February 11, ...

Q. I’ve heard the term “shock” a million times, but I realized that I don’t really know what it means. What is shock? A. Shock is a condition in which blood pressure is too low and not ...

WARRINGTON, Pa. - Windtree Therapeutics, Inc. (NASDAQ:WINT), a biotechnology firm specializing in the development of therapies for critical diseases and currently valued at $1.44 million market ...

Are you searching for effective medications to treat 'Cardiogenic Shock'? This comprehensive guide provides the latest information on medications-both generic and branded-that are essential for ...

For 5 weeks, the tiny Impella kept Katrina Penney's failed heart pumping while a second heart transplant was secured.

Discover how heart centers across the country are improving patient outcomes and reducing mortality rates through innovative approaches and advanced therapies.

Cardiogenic shock occurs when the heart is not able to pump enough blood to generate adequate cardiac output to maintain normal blood pressure. This frequently occurs in the setting of a large ...